These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis. Zaman MU, Fatima N, Sajjad Z, Hashmi I, Khan K. Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858 [Abstract] [Full Text] [Related]
5. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (99mTc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms. Higashiyama S, Yoshida A, Kawabe J. Curr Med Imaging; 2021 Oct; 17(1):89-96. PubMed ID: 32484112 [Abstract] [Full Text] [Related]
7. Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer. Saylor PJ, Mahmood U, Kunawudhi A, Smith MR, Palmer EL, Michaelson MD. J Nucl Med; 2012 Nov; 53(11):1670-5. PubMed ID: 22984218 [Abstract] [Full Text] [Related]
8. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate. al-Nahhas AM, Jinnouchi S, Anagnostopoulos C, Hirsch W, Heary T, McCready VR. Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502 [Abstract] [Full Text] [Related]
9. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate. Amin A, El-Kareem MA, Yahia AB. Nucl Med Rev Cent East Eur; 2015 Feb; 18(2):61-4. PubMed ID: 26315864 [Abstract] [Full Text] [Related]
10. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer. Anand A, Morris MJ, Kaboteh R, Båth L, Sadik M, Gjertsson P, Lomsky M, Edenbrandt L, Minarik D, Bjartell A. J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832 [Abstract] [Full Text] [Related]
11. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature. Ergün EL, Kiratli PO, Günay EC, Erbaş B. Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428 [Abstract] [Full Text] [Related]
12. Dosimetric considerations of 99mTc-MDP uptake within the epiphyseal plates of the long bones of pediatric patients. Brown JL, Sexton-Stallone B, Li Y, Frey EC, Treves ST, Fahey FH, Plyku D, Cao X, Choi C, Kim CH, Sgouros G, Aris JP, Bolch WE. Phys Med Biol; 2020 Dec 02; 65(23):235025. PubMed ID: 33263312 [Abstract] [Full Text] [Related]
13. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication. Buell U, Kleinhans E, Zorn-Bopp E, Reuschel W, Muenzing W, Moser EA, Seiderer M. J Nucl Med; 1982 Mar 02; 23(3):214-7. PubMed ID: 6460854 [Abstract] [Full Text] [Related]
14. Soft-tissue uptake of Tc-99m MDP in secondary scrotal lymphedema. Rao BR, Hodgens DW. J Nucl Med; 1983 Mar 02; 24(3):275. PubMed ID: 6219192 [No Abstract] [Full Text] [Related]
16. Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast. Zhang W, Chen B, Deng H, Yang T, Ou X. Clin Nucl Med; 2013 Mar 02; 38(3):219-20. PubMed ID: 23412599 [Abstract] [Full Text] [Related]